AMA holds off on backing ad ban, will study effects of marketing

AMA holds off on backing ad ban, will study effects of marketing 

 

After considering backing limitations on consumer drug ads, the American Medical Association (AMA) voted this week instead to authorize a comprehensive study on the effects of DTC advertising, according to the Chicago Tribune. The study will examine whether DTC drug ads lead to higher costs, unnecessary prescribing, or other negative results, AMA's House of Delegates decided during a meeting in Chicago. Although the AMA says backing a ban is not out of the question, the report will give a more balanced look at how drug advertising affects consumers as Congress debates restricting the practice, the Tribune reports.